Kartal Koşuyolu Araştırma Yüksek İhtisas Eğitim ve Hastanesi PERKÜTAN MİTRAL KAPAK TAMİRİ Endikasyonlar ve Klinik Çalışmalar kapak tamir atölyesi 1-2 Kasım 2013, İSTANBUL Dr. Selçuk Pala Kartal Koşuyolu Araştırma Yüksek İhtisas Eğitim ve Hastanesi
European Heart Journal (2007) 28, 1358–1365
EVEREST I (Endovascular Valve Edge-to-Edge Repair) inclusion criteria All patients were potential candidates for MV surgery symptomatic and/or had compromised LV function(LVEF <60% or LVESD >45 mm). With regard to MR severity, patients met at least three out of six criteria for severity, one of which was quantitative.
EVEREST I exclusion criteria Etiology of MR being infectious or rheumatic LVEF of <30% LVES dimension of >55 mm MV area of <4.0 cm2
EVEREST I
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II
EVEREST II HRR
EVEREST II comparator group (n= 36)
EVEREST HRS
EVEREST II HRS
EVEREST HRS
ACCESS EU
ACCESS EU
ACCESS EU
ACCESS EU
ESC
SUMMARY The MitraClip procedure can be performed safely with low major advers event rate. Beyond 6 months, the rate of MV surgery low in the MitraClip patients
SUMARY SURGERY İS the standard of care for treatment of MR among elegible patient
SUMMARY Clinical benefits provided by MitraClip is durable through 4 years ** Reduced in MR severity ** İmprovment in LV Dimension ** İmprovments in NYHA Functional Class
Conclusion The MitraClip procedure is a therapeutic option for selected patients with significant MR
Kartal Koşuyolu Araştırma Yüksek İhtisas Eğitim ve Hastanesi PERKÜTAN MİTRAL KAPAK TAMİRİ Endikasyonlar ve Klinik Çalışmalar kapak tamir atölyesi 1-2 Kasım 2013, İSTANBUL Dr. Selçuk Pala Kartal Koşuyolu Araştırma Yüksek İhtisas Eğitim ve Hastanesi